Harpreet Singh

13PUBLICATIONS
104CO-AUTHORS
Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Food properties (incl. characteristics and health benefits)Cancer geneticsAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.

Sonia Singh, Diana Bradford, Somak Chatterjee

|Nov 12, 2024
Administrative Aspects of Molecular Diagnostics-Oversight, Regulatory Approval Process, Clinical and Operational Workflows, and Payment Models.

Lalan Wilfong, Lauren Baggett, Philip Reena

|Jun 25, 2024
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy.

Elizabeth S Duke, Diana Bradford, Arup K Sinha

|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.

Michael I Barbato, Diana Bradford, Yi Ren

|Feb 15, 2024
Considering Functional Outcomes as Efficacy Endpoints in Pediatric Low-Grade Glioma Clinical Trials: An FDA Educational Symposium.

Jason Fangusaro, Robert A Avery, Michael J Fisher

|Dec 12, 2023
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.

Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco

Pageof 3

Frequent Collaborators

9 joint publications

Richard Pazdur

7 joint publications

Pallavi S Mishra-Kalyani

6 joint publications

Diana Bradford

5 joint publications

Paul G Kluetz